Vol 8, No 1 (February 28, 2019): Translational Andrology and Urology (Management of Non-muscle Invasive Bladder Cancer)

Preface

The present and future of non-muscle invasive bladder cancer
Marco Moschini, Florian Roghmann, Evanguelos Xylinas
Translational Andrology and Urology  
2019;
8
(1)
:1
.

Editorial

The need to improve TURB: a diagnostic and therapeutic fundamental first step in the disease’s management
Marco Moschini, Florian Roghmann, Evanguelos Xylinas
Translational Andrology and Urology  
2019;
8
(1)
:2-4
.

Review Article

Epidemiology, aetiology and screening of bladder cancer
Marcus G. K. Cumberbatch, Aidan P. Noon, on behalf of the EAU Young Academic Urologists— Urothelial Cancer working party
Translational Andrology and Urology  
2019;
8
(1)
:5-11
.
Review on gender differences in non-muscle invasive bladder cancer
Konrad Bilski, Łukasz Zapała, Michał A. Skrzypczyk, Maciej Oszczudłowski, Jakub Dobruch
Translational Andrology and Urology  
2019;
8
(1)
:12-20
.

Mini-Review

Contemporary surgical and technical aspects of transurethral resection of bladder tumor
Idir Ouzaid, Fréderic Panthier, Jean-François Hermieu, Evanguelos Xylinas
Translational Andrology and Urology  
2019;
8
(1)
:21-24
.

Review Article

Transurethral resection of bladder tumours: established and new methods of tumour visualisation
Karl Tully, Rein-Jüri Palisaar, Marko Brock, Peter Bach, Nicolas von Landenberg, Björn Löppenberg, Christian von Bodman, Joachim Noldus, Florian Roghmann
Translational Andrology and Urology  
2019;
8
(1)
:25-33
.
Histological variants in non-muscle invasive bladder cancer
Philipp Baumeister, Stefania Zamboni, Agostino Mattei, Alessandro Antonelli, Claudio Simeone, Livio Mordasini, Carlo DiBona, Marco Moschini
Translational Andrology and Urology  
2019;
8
(1)
:34-38
.
Prediction tools in non-muscle invasive bladder cancer
Stefania Zamboni, Marco Moschini, Claudio Simeone, Alessandro Antonelli, Agostino Mattei, Philipp Baumeister, Evanguelos Xylinas, Oliver W. Hakenberg, Atiqullah Aziz
Translational Andrology and Urology  
2019;
8
(1)
:39-45
.
The rational and benefits of the second look transurethral resection of the bladder for T1 high grade bladder cancer
Francesco Soria, Giancarlo Marra, David D’Andrea, Paolo Gontero, Shahrokh F. Shariat
Translational Andrology and Urology  
2019;
8
(1)
:46-53
.
Active surveillance for non-muscle invasive bladder cancer
Gautier Marcq, François Hénon, Idir Ouzaid, Jean Christophe Fantoni, Jean-François Hermieu, Evanguelos Xylinas
Translational Andrology and Urology  
2019;
8
(1)
:54-60
.
The current role of circulating biomarkers in non-muscle invasive bladder cancer
Michael Rink, Heidi Schwarzenbach, Malte W. Vetterlein, Sabine Riethdorf, Armin Soave
Translational Andrology and Urology  
2019;
8
(1)
:61-75
.
Single postoperative instillation for non-muscle invasive bladder cancer: are there still any indication?
Stefania Zamboni, Philipp Baumeister, Agostino Mattei, Livio Mordasini, Alessandro Antonelli, Claudio Simeone, Marco Moschini
Translational Andrology and Urology  
2019;
8
(1)
:76-84
.
Intravesical bacillus Calmette-Guérin for bladder cancer: are all the strains equal?
David D’Andrea, Paolo Gontero, Shahrokh F. Shariat, Francesco Soria
Translational Andrology and Urology  
2019;
8
(1)
:85-93
.
Device-assisted intravesical therapy for non-muscle invasive bladder cancer
Kees Hendricksen
Translational Andrology and Urology  
2019;
8
(1)
:94-100
.
Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer
Karl H. Pang, Aidan P. Noon, on behalf of the EAU Young Academic Urologists-Urothelial Cancer Working party
Translational Andrology and Urology  
2019;
8
(1)
:101-107
.

Disclosure:

The focused issue “Management of Non-muscle Invasive Bladder Cancer” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Marco Moschini, Florian Roghmann and Evanguelos Xylinas served as the unpaid Guest Editors for the focused issue.